Skip to main content
TipRanks
Go Ultimate75% OFF

James F. Reddoch Insider Profile

4 Followers

James F. Reddoch, EVP & Chief Scientific Officer at Royalty Pharma, holds 845.83K shares in Royalty Pharma (Ticker: RPRX). Most recently, James F. Reddoch Sold 100,000 shares of Royalty Pharma on Sep 30, 2022 for an estimated value of $4.12M.

James F. Reddoch's Trading History

RPRX
Royalty Pharma
Sep 30, 2022EVP & Chief Scientific OfficerInformative Sell4.12M$57.96M
RPRX
Insider Shares: 845.83K (0.19%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 30, 2022Informative Sell$4.12M100,000$41.22+30.90%
Jun 10, 2022Informative Sell$4.16M100,000$41.55+17.00%
May 31, 2022Informative Sell$3.08M75,000$41.08+18.80%
May 23, 2022Informative Sell$3.03M75,000$40.44+15.70%
Jul 27, 2021Uninformative Sell$355.90K8,949$39.77―

You May Also Like

James F. Reddoch insider profile FAQ

What is the percentage of profitable transactions made by James F. Reddoch?
The percentage of profitable transactions made by James F. Reddoch is 100%.
What is the average return per transaction made by James F. Reddoch?
The average return per transaction made by James F. Reddoch is 18.20%.
What stocks does James F. Reddoch hold?
James F. Reddoch holds: RPRX stocks.
What was James F. Reddoch’s latest transaction?
James F. Reddoch’s latest transaction was an Informative Sell of $4.12M.
What was James F. Reddoch's most profitable transaction?
James F. Reddoch’s most profitable transaction was an Informative Sell of RPRX stock on September 30, 2022. The return on the trade was 30.90%.
What is James F. Reddoch's role in Royalty Pharma?
James F. Reddoch's role in Royalty Pharma is EVP & Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.